Drug development

Genomics has the potential to significantly improve the efficacy of drugs and develop targeted therapies.

GSK and 23andMe Agree to $300M Deal

Pharmaceutical giant GlaxoSmithKline has bought a $300 million stake in genetic DTC testing company 23andMe to help further their genetics-based drug discovery.

Weekend Reads

This week: Are the conclusion about ‘alien’ mummy, Ata correct? Where is the African DNA in the search for cures? And is it possible to bury family secrets in the age of DNA testing?